Literature DB >> 19259620

Inverse relationship between multiple sclerosis and allergic respiratory diseases.

Roberto Bergamaschi1, Simona Villani, Massimo Crabbio, Michela Ponzio, Alfredo Romani, Anna Verri, Valeria Bargiggia, Vittorio Cosi.   

Abstract

Th1 up-regulation seems to favour autoimmunity, while Th2 up-regulation seems to favour humoral immunity. Accordingly, subjects affected by atopic diseases (such as allergic respiratory diseases, ARDs) should be less prone to autoimmune diseases (such as multiple sclerosis, MS), and vice versa. The recent identification of Th17 cells, which seem to favour the development of both autoimmunity and allergy, led to the revision of the classic Th1/Th2 paradigm. We studied 200 MS patients and 200 controls to analyze the relationships between ARDs and MS. MS patients had less probability to suffer from ARDs (OR = 0.30, p < 0.001) and allergic rhinitis (OR = 0.25, p < 0.001), after adjusting for environmental factors. MS tended to be less severe when associated to ARDs. Our findings add some elements for the comprehension of immune mechanisms involved in MS pathogenesis and suggest to analyze other MS cohorts, in order to evaluate if MS patients affected by allergic diseases show particular clinical findings.

Entities:  

Mesh:

Year:  2009        PMID: 19259620     DOI: 10.1007/s10072-009-0036-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.

Authors:  S Molet; Q Hamid; F Davoine; E Nutku; R Taha; N Pagé; R Olivenstein; J Elias; J Chakir
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

2.  Prevalence of atopy in multiple sclerosis patients: a case-control study.

Authors:  C Solaro; M Messmer Uccelli; P Guglieri; A Murialdo; M P Sormani; M A Battaglia; G L Mancardi
Journal:  J Neurol       Date:  2001-03       Impact factor: 4.849

3.  The European Community Respiratory Health Survey II.

Authors: 
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

Review 4.  Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases.

Authors:  Rosetta Pedotti; Jason J De Voss; Lawrence Steinman; Stephen J Galli
Journal:  Trends Immunol       Date:  2003-09       Impact factor: 16.687

5.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

6.  A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic.

Authors:  L J Edwards; C S Constantinescu
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

Review 7.  Th17 and allergy.

Authors:  Keisuke Oboki; Tatsukuni Ohno; Hirohisa Saito; Susumu Nakae
Journal:  Allergol Int       Date:  2008-06       Impact factor: 5.836

Review 8.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.

Authors:  Parris Kidd
Journal:  Altern Med Rev       Date:  2003-08

9.  Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.

Authors:  Ruth Arnon; Rina Aharoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  11 in total

Review 1.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 2.  The pathologic and clinical intersection of atopic and autoimmune disease.

Authors:  Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

3.  Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.

Authors:  Mireia Guerau-de-Arellano; Kristen M Smith; Jakub Godlewski; Yue Liu; Ryan Winger; Sean E Lawler; Caroline C Whitacre; Michael K Racke; Amy E Lovett-Racke
Journal:  Brain       Date:  2011-11-15       Impact factor: 13.501

4.  Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population.

Authors:  Theresa Bourne; Michael Waltz; T C Casper; K Kavak; G Aaen; A Belman; L Benson; M Candee; T Chitnis; J Graves; B Greenberg; M Gorman; Y Harris; L Krupp; T Lotze; S Mar; J Ness; C Olsen; S Roalstad; M Rodriguez; J Rose; J Rubin; T Schreiner; J M Tillema; I Kahn; A Waldman; L Barcellos; E Waubant; B Weinstock-Guttman
Journal:  J Neurol Sci       Date:  2017-02-20       Impact factor: 3.181

5.  A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy.

Authors:  Fabrizio Salvi; Ilaria Bartolomei; Michael H Smolensky; Angelo Lorusso; Elena Barbarossa; Anna Maria Malagoni; Paolo Zamboni; Roberto Manfredini
Journal:  BMC Neurol       Date:  2010-11-01       Impact factor: 2.474

6.  Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study.

Authors:  Ali Manouchehrinia; Laura J Edwards; Homayoun Roshanisefat; Christopher R Tench; Cris S Constantinescu
Journal:  BMJ Open       Date:  2015-05-20       Impact factor: 2.692

Review 7.  The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.

Authors:  Ruth Ann Marrie; Nadia Reider; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary R Cutter; Stephen C Reingold; Jeffrey Cohen
Journal:  Mult Scler       Date:  2014-12-23       Impact factor: 6.312

Review 8.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

9.  Fish and egg specific immunoglobin e in multiple sclerosis patients.

Authors:  Fereshteh Ashtari; Fatemeh Jamshidi; Raheleh Shokouhi Shoormasti; Zahra Pourpak; Mojtaba Akbari; Faiborz Zandieh
Journal:  Int J Prev Med       Date:  2013-05

10.  Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease.

Authors:  Pritash Patel; Jonathan Brostoff; Helen Campbell; Rishi M Goel; Kirstin Taylor; Shuvra Ray; Miranda Lomer; Michael Escudier; Stephen Challacombe; Jo Spencer; Jeremy Sanderson
Journal:  Clin Transl Allergy       Date:  2013-08-15       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.